Phosphatidylethanolamine plasmalogen
lipidPhosphatidylethanolamine plasmalogen provides antioxidant cardioprotection during myocardial ischemia-reperfusion injury.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleCardioprotective lipid; reduces ischemic injury and oxidative stress.
Also acts inLipid entry/oxidation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(1)
- Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction.PloS one · 2015 · PMID 26258408 · doi